Katie Partyka

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers

Tingting Yue, Kevin A. Maupin, Brian P. Fallon et al. · PLoS ONE · 2011 · 75 citations · Full text

Specific Protein Carriers, Oncology, Pancreatic Cancer +15

Identification of blood‐protein carriers of the CA 19‐9 antigen and characterization of prevalence in pancreatic diseases

Tingting Yue, Katie Partyka, Kevin A. Maupin et al. · PROTEOMICS · 2011 · 65 citations · Full text

Pancreatic Diseases, Prognostic Biomarkers, Pancreatic Cancer +15

MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)

Steven N. Reuland, Shilo M. Smith, Lynne Bemis et al. · Journal of Investigative Dermatology · 2012 · 58 citations · Full text

Tumor Biology, Medicine, Melanoma +12

Diverse monoclonal antibodies against the <scp>CA</scp> 19‐9 antigen show variation in binding specificity with consequences for clinical interpretation

Katie Partyka, Kevin A. Maupin, Randall E. Brand et al. · PROTEOMICS · 2012 · 57 citations · Full text

Clinical Immunology, Immunocytochemical Technique, Clinical Interpretation +19

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis

Ben Staal, Ying Liu, Daniel Barnett et al. · Clinical Cancer Research · 2019 · 48 citations · Full text